Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes

计划入组 30 人 · 首次发布于 2020 年 11 月 12 日

Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes

首次发布于 2018 年 1 月 11 日

"Adding DNA-test for Screening of HLA-DQ2 and DQ8 to Improve Early Diagnosis of Celiac Disease"

计划入组 508 人 · 首次发布于 2023 年 12 月 21 日

HLA-DQ2/DQ8 inhibitors (Provid)

D38

DQP-1105

Diamyd Medical Secures Key Patents for Precision Medicine Approach to Type 1 Diabetes Treatment

South Korea Grants Diamyd Medical Patent for Insulin Antigen Therapy in Autoimmune Diabetes

Diamyd Medical Partners with INNODIA to Boost Type 1 Diabetes Trial